Hematogenix was established in 2007. The goal was to build a different kind of esoteric reference laboratory - one that puts patients and their care first. No venture capitalists, no publicly traded board, no big business and no pressure to provide high profits that could compromise patient care.From the beginning, Hematogenix established testing protocols that ensure each patient's individual medical history and stage of disease is taken into account. It is priority to ensure that every test ordered is truly needed and will yield valuable clinical insight.Today, our state-of-the-art facilities in both USA & Europe (UK) span 32,000 square feet and are specially designed to optimize work flow and promote department collaboration. Our scientific space houses advanced technologies from the top laboratory equipment manufacturers. Often times, we are the first commercial site to house leading edge instrumentation.Hematogenix offers a comprehensive array of services designed to navigate the complexities of human subject clinical trials. Our deep research and clinical laboratory experience enable us to resolve emerging challenges found in clinical trials. Hematogenix provides logistic management of tissue and sample procurement, distributes collection kits and contributes to standards and procedures required for initiating a clinical trial. Powered by a state-of-the-art laboratory information system, Hematogenix facilities and practices comply with rigorous chain of custody and specimen management practices. We are a CAP, CLIA and GCP compliant laboratory.We offer Clinical Trail Biomarker Services including: Flow Cytometry, FISH, IHC, mRNA ISH, PCR, Sequencing, & more, Biomarker Assay Development, Companion Diagnostics, Bio Banking Services, Bone Marrow, Blood, & Solid Tumors.